| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.029 | 0.9 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.0082 | 0.9 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.0052 | 0.9 |